Monday, 26 November 2018
Researchers from CSIC, ICN2 and CIBER-BBN have designed a biosensor device based on gold nanostructures that precisely detects the presence of anticoagulant drug from a small blood sample. Treatments with anticoagulants such as Sintrom® (acenocoumarol) face the difficulty of adjusting the drug doses. This device will allow patients to self-regulate the dose.
Monday, 19 November 2018
As we advanced last July, the ICN2 is among the five centres and seven units to be recognised in this round of Severo Ochoa and María de Maeztu awards, renewing our status as a national centre of excellence.
Tuesday, 13 November 2018
As a member of the board, the ICN2 Group Leader will support the proud Danish science tradition and its development.
Wednesday, 14 November 2018
Imagine you wanted to build a device that could allow people with severe speech impairment to engage in everyday conversation. How would you go about it? Coordinator of the European BrainCom project, ICREA Prof. Jose A. Garrido talks us through the process of building the right team.
Tuesday, 13 November 2018
This ICN2 group leader was recently elected member of the Board of Stakeholders of the European Technology Platform, Photonics21.
